ArticleJournal of surgical case reports2015
Basal cell carcinoma arising in a sebaceous naevus.
Article in Journal of surgical case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- A case of naevus sebaceus of Jadassohn of the scalp in Jamaica.Journal of surgical case reports · 2021Article
- More Than Skin Deep: A Case of Nevus Sebaceous Associated With Basal Cell Carcinoma Transformation.Cureus · 2020Article
- Basal cell carcinoma arising in a congenital melanocytic naevus in an adult.BMJ case reports · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sebaceous naevus is a rare non-melanocytic congenital skin hamartoma. Even more rare is the transformation of these lesions into malignant skin cancers, most notably basal cell carcinomas (BCCs). We discuss a case in an adult with later malignant transformation into BCC reported by clinical pathologists. There is dispute about the accurate incidence of malignant transformation. More recently, research has shown that transformation into BCC is unlikely, in that the origins of these lesions arise in trichoblastoma. Evidence from this comes from the changes in mutation pathways that are distinctly separate. A consensus between dermatology, plastic surgery and clinical pathologists is beneficial to decide the best management for these individuals. The limiting factor is the agreement of diagnosis, compounded with conflicting large series multi-centre trials to determine the likelihood of transformation. We feel that each case should be managed individually taking into account patient and/or parent preference with the surgeon offering advice to help the patient guide management decisions. Patient/parent education is important and long-term follow-up by plastic surgeons or dermatologists is highly recommended.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.